We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Some Phase I Drugs May Be Exempt From GMP Requirements
Some Phase I Drugs May Be Exempt From GMP Requirements
August 19, 2008
After withdrawing a final rule more than two years ago to exempt investigational drugs in Phase I testing from certain good manufacturing practice (GMP) regulations, the U.S. Food and Drug Administration (FDA) is issuing another final rule that will do just that.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor